Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medi-Weightloss vs NativeMed

Medi-Weightloss
Graded #126

Higher grade

vs+3.0999999999999943
NativeMed
Graded #191

Lower grade

The verdict

Medi-Weightloss takes it — 69.6/100 to 66.5/100.

Medi-Weightloss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medi-Weightloss is an established physician-supervised weight-loss brand with 130-plus locations nationwide plus telehealth.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNativeMed +20
54
74
Dose & formulationMedi-Weightloss +1
65
64
Clinical oversightMedi-Weightloss +13
87
74
Labs & monitoringMedi-Weightloss +37
90
53
FulfillmentNativeMed +2
65
67
Contract termsEven
55
55
Medi-Weightloss · left barNativeMed · right bar

The numbers

MetricMedi-WeightlossNativeMed
WeighScore69.6/10066.5/100
GradeCC
Scorecard rank#126#191
Semaglutide$199/mo (promotional rate, brand-name)$149/mo (promotional rate, compounded)
TirzepatideNot disclosed$183/mo (promotional rate, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Medi-Weightloss

Graded #126 · C

Strengths

  • Both branded (Wegovy, Zepbound) and compounded semaglutide/tirzepatide
  • Established brand with 130+ physician-supervised locations nationwide
  • Telehealth plus in-person clinic options
  • Accepts insurance at many locations; HSA/FSA welcome
  • Includes body-composition analysis and personalized plans

Where it loses points

  • Ongoing medication pricing not transparently posted; varies by plan
  • $199 new-patient visit fee before medication costs
  • Frequent (often weekly) visits expected for some patients
  • Compounded products are not FDA-approved or evaluated
NativeMed

Graded #191 · C

Strengths

  • LegitScript Certified (verifiable in the footer)
  • Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
  • Online questionnaire intake, with a live visit added when state law requires it

Where it loses points

  • Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
  • States served aren't listed publicly
  • Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard